Beta Bionics (BBNX) Accounts Payables (2023 - 2026)

Beta Bionics has disclosed Accounts Payables across 4 years of filings, most recently posting $2.3 million for Q1 2026.

• Accounts Payables for Q1 2026 came in at $2.3 million, down 32.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 million (down 32.89% YoY), and the FY2025 annual result was $5.0 million, up 75.25% from the prior year.
• Accounts Payables came in at $2.3 million for Q1 2026 at Beta Bionics, down from $5.0 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $5.0 million in Q4 2025 to a low of $1.2 million in Q4 2023.
• The 4-year median for Accounts Payables is $3.4 million (2025), against an average of $3.2 million.
• Across the five-year window, Accounts Payables jumped 144.6% in 2024 and plunged 32.89% in 2026, its largest moves.
• Beta Bionics' Accounts Payables stood at $1.2 million in 2023, then jumped by 144.6% to $2.9 million in 2024, then surged by 75.25% to $5.0 million in 2025, then slumped by 53.62% to $2.3 million in 2026.
• The last three Accounts Payables figures came in at $2.3 million (Q1 2026), $5.0 million (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.